ApoGen increases 2016 Series A funding round to $11 million
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
ApoGen secures $7M Series A with Accelerator Corporation
With a $7 million Series A financing round, ApoGen has become the latest startup to enter Accelerator Corporation's syndicate funding and operational support program. It's a strong endorsement from a firm which makes very few investments.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.